Introduction. The pathogenesis of schizophrenia is associated with disruptions in the phospholipid layer of cell membranes, imbalances in polyunsaturated fatty acids, and a deficiency in vitamin B3. These mechanisms lead to an abnormal reaction to the niacin skin test, characterized by a decrease or absence of skin hyperemia.
The objective of the study was to evaluate the diagnostic value of the niacin skin test in patients with schizophrenia by analyzing key statistical indicators.
Materials and methods. A total of 61 studies published between 1997 and 2022 were included, encompassing 1,283 patients with schizophrenia and a control group of 854 healthy subjects.
Results. The niacin skin test demonstrated a predictive probability of 78.5% for identifying schizophrenia in patients with a positive test result and a probability of 71.09% for correctly identifying healthy individuals with a negative test result.
Conclusions. The niacin skin test shows potential as a biomarker for schizophrenia. However, standardized protocols for its application, quantification, and the inclusion of additional parameters are essential for future research and broader clinical application.
Keywords: schizophrenia, niacin skin test, sensitivity, specificity, high-risk psychosis.
How to cite Email to Author
Address for correspondence:
Igor NASTAS
Department of Mental Health, Medical Psychology and Psychotherapy, Nicolae Testemitanu State University of Medicine and Pharmacy, Chisinau, Republic of Moldova
E-mail: igor.nastas@usmf.md, Phone: +37367133770